SOURCES: Richard J. Rudolph, MD, chief medical officer, Cyberonics Inc. Kyra J. Becker, MD, University of Washington School of Medicine, FDA Neurological Devices Advisory Panel chairwoman. Richard P. Malone, MD, professor of psychiatry and epidemiology, Brigham and Women's Hospital. Michael J. Schlosser, MD, FDA medical officer. Laura J. Fochtmann, MD, State University of New York, Stony Brook. A. John Rush, MD, University of Texas Southwestern Medical Center; consultant, Cyberonics, Inc.